ストックスクリーナーアプリを入手
0.4792
5.58%
-0.0408
前日終値:
$0.52
開ける：
$0.5113
24時間の取引高:
52,480
Relative Volume:
0.01
時価総額：
$2.08M
収益：
$75,000
当期純損益:
$-40.08M
株価収益率:
-0.00247
EPS:
-193.9456
ネットキャッシュフロー:
$-16.26M
1週間 パフォーマンス:
-9.31%
1か月 パフォーマンス:
-73.46%
6か月 パフォーマンス:
-96.51%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.472
$0.5235
1週間の範囲:
$0.4907
$0.6226
52週間の値動き範囲:
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.472 | 2.29M | 75,000 | -40.08M | -16.26M | -193.95 |
ABT
Abbott Laboratories
|
86.51 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
293.27 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.33 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.34 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.46 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Profusa Inc (PFSA) 最新ニュース
Profusa initiates strategic review, focuses on European approval By Investing.com - Investing.com Australia
Profusa Inc Profusa initiates board-led process to evaluate strategic alternatives and maximize shareholder value - marketscreener.com
Profusa starts deal review after Lumee Oxygen completes two EU audits - Stock Titan
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value - Moomoo
[EFFECT] Profusa, Inc. SEC Filing - Stock Titan
Profusa (PFSA) registers 179.3M resale shares, up to $100M ELOC funding - Stock Titan
Profusa (NASDAQ: PFSA) files S-1 for 179M-share resale and $100M equity line - Stock Titan
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why did PFSA stock surge 80% pre-market today? - MSN
Profusa Faces Nasdaq Listing Risk Amid Financing Amendments - TipRanks
Profusa amends debt agreement and receives Nasdaq deficiency notice - Investing.com
Profusa amends debt agreement and receives Nasdaq deficiency notice By Investing.com - Investing.com Canada
Profusa Updates Financing Terms: Note Now Convertible; 19.99% Cap Added; Warrant Amended - TradingView
Profusa (NASDAQ: PFSA) revises convertible note as Nasdaq listing risk rises - Stock Titan
Profusa (PFSA) resale S-1 details 179M shares and $100M equity line - Stock Titan
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Announces PanOmics Assay Know-How Acquisition Agreement - TipRanks
Profusa to Acquire PanOmics Assay Know-How From Bio Insights for $30 Million in Preferred Stock - TradingView
Profusa (NASDAQ: PFSA) to acquire PanOmics assay assets in $30M stock deal - Stock Titan
Profusa, Inc. Issues $1.1 Million Senior Secured Convertible Promissory Note and Warrant to Ascent Partners Fund LLC - Minichart
Profusa Secures New Convertible Note and Warrant Financing - TipRanks
Profusa Raises $1.0 Million From Ascent via Secured Convertible Note; Issues $0.50 Warrant, Adds Lock-Up - TradingView
Profusa (NASDAQ: PFSA) adds secured convertible note and 3.33M-share warrant - Stock Titan
Profusa (PFSA) Stock Dividend Growth (Underperforming) 2026-04-20Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
What's going on with Profusa stock Tuesday? - MSN
Profusa’s Next-Generation Biosensor Technology: Real-Time Biochemistry Monitoring for Chronic Disease Management and Telemedicine Applications - Minichart
Profusa, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Profusa (NASDAQ: PFSA) outlines Lumee biosensor pipeline, funding and 1-for-75 reverse split - Stock Titan
Profusa, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Is Profusa (PFSA) Stock Good for Beginners | Price at $0.86, Down 17.62%Risk Reward Ratio - UBND thành phố Hải Phòng
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Crude Oil Gains 3%; Alignment Healthcare Shares Jump - Sahm
Dow Falls 200 Points; US Durable Goods Orders Decline In February - Sahm
Gold Edges Higher; ISM Services PMI Falls In March - Sahm
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
What's Going On With Profusa Stock Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Profusa expands into precision diagnostics market - Medical Buyer
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform - bitget.com
Profusa to acquire multi-omics platform, partners with Mayo Clinic By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
Monday's session: top gainers and losers - ChartMill
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Curious about the most active stocks on Monday? - ChartMill
Profusa shares surge after $30M PanOmics acquisition LOI signals pivot into molecular diagnostics - Quiver Quantitative
Profusa (PFSA) Stock Soars 173% on $30M PanOmics Diagnostics Acquisition - Blockonomi
US Stocks Mixed; Nasdaq Gains Over 100 Points - Benzinga
Profusa Inc (PFSA) 財務データ
収益
当期純利益
現金流量
EPS
0.76%
0.72%
大文字化:
|
ボリューム (24 時間):